Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?

Noton K. Dutta, Petros C. Karakousis

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article number1117
JournalFrontiers in Microbiology
Volume6
Issue numberOCT
DOIs
StatePublished - Jan 1 2015

Keywords

  • Animal models
  • Clinical trial
  • Mycobacterium tuberculosis
  • Persistence
  • Reactivation
  • Rifampicin
  • Treatment improvement

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this